These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22450967)

  • 21. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
    González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
    Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the substrate specificity of the Plasmodium M1 and M17 aminopeptidases.
    Malcolm TR; Swiderska KW; Hayes BK; Webb CT; Drag M; Drinkwater N; McGowan S
    Biochem J; 2021 Jul; 478(13):2697-2713. PubMed ID: 34133730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development.
    Stack CM; Lowther J; Cunningham E; Donnelly S; Gardiner DL; Trenholme KR; Skinner-Adams TS; Teuscher F; Grembecka J; Mucha A; Kafarski P; Lua L; Bell A; Dalton JP
    J Biol Chem; 2007 Jan; 282(3):2069-80. PubMed ID: 17107951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling of human leucyl aminopeptidases for in silico off target binding analysis of potential Plasmodium falciparum leucine aminopeptidase (PfA-M17) specific inhibitors.
    Sahi S; Raj U; Chaudhary M; Nain V
    Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(3):191-201. PubMed ID: 25269653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoproteomics validates selective targeting of
    Giannangelo C; Challis MP; Siddiqui G; Edgar R; Malcolm TR; Webb CT; Drinkwater N; Vinh N; Macraild C; Counihan N; Duffy S; Wittlin S; Devine SM; Avery VM; De Koning-Ward T; Scammells P; McGowan S; Creek DJ
    Elife; 2024 Jul; 13():. PubMed ID: 38976500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity.
    Chen X; Chong CR; Shi L; Yoshimoto T; Sullivan DJ; Liu JO
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14548-53. PubMed ID: 16983082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-ray crystal structures of an orally available aminopeptidase inhibitor, Tosedostat, bound to anti-malarial drug targets PfA-M1 and PfA-M17.
    Drinkwater N; Bamert RS; Sivaraman KK; Paiardini A; McGowan S
    Proteins; 2015 Apr; 83(4):789-95. PubMed ID: 25645579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aminobenzosuberone derivatives as PfA-M1 inhibitors: Molecular recognition and antiplasmodial evaluation.
    Salomon E; Schmitt M; Mouray E; McEwen AG; Bounaadja L; Torchy M; Poussin-Courmontagne P; Alavi S; Tarnus C; Cavarelli J; Florent I; Albrecht S
    Bioorg Chem; 2020 May; 98():103750. PubMed ID: 32182520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based development of potent Plasmodium falciparum M1 and M17 aminopeptidase selective and dual inhibitors via S1'-region optimisation.
    Calic PPS; Vinh NB; Webb CT; Malcolm TR; Ngo A; Lowes K; Drinkwater N; McGowan S; Scammells PJ
    Eur J Med Chem; 2023 Feb; 248():115051. PubMed ID: 36634455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening the Medicines for Malaria Venture "Malaria Box" against the Plasmodium falciparum aminopeptidases, M1, M17 and M18.
    Paiardini A; Bamert RS; Kannan-Sivaraman K; Drinkwater N; Mistry SN; Scammells PJ; McGowan S
    PLoS One; 2015; 10(2):e0115859. PubMed ID: 25700165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxamic Acid Inhibitors Provide Cross-Species Inhibition of Plasmodium M1 and M17 Aminopeptidases.
    Vinh NB; Drinkwater N; Malcolm TR; Kassiou M; Lucantoni L; Grin PM; Butler GS; Duffy S; Overall CM; Avery VM; Scammells PJ; McGowan S
    J Med Chem; 2019 Jan; 62(2):622-640. PubMed ID: 30537832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Validation of a Potent Dual Inhibitor of the P. falciparum M1 and M17 Aminopeptidases Using Virtual Screening.
    Ruggeri C; Drinkwater N; Sivaraman KK; Bamert RS; McGowan S; Paiardini A
    PLoS One; 2015; 10(9):e0138957. PubMed ID: 26406322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metalloaminopeptidases of the Protozoan Parasite
    Mills B; Isaac RE; Foster R
    J Med Chem; 2021 Feb; 64(4):1763-1785. PubMed ID: 33534577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells.
    Krige D; Needham LA; Bawden LJ; Flores N; Farmer H; Miles LE; Stone E; Callaghan J; Chandler S; Clark VL; Kirwin-Jones P; Legris V; Owen J; Patel T; Wood S; Box G; Laber D; Odedra R; Wright A; Wood LM; Eccles SA; Bone EA; Ayscough A; Drummond AH
    Cancer Res; 2008 Aug; 68(16):6669-79. PubMed ID: 18701491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin.
    Gardiner DL; Trenholme KR; Skinner-Adams TS; Stack CM; Dalton JP
    J Biol Chem; 2006 Jan; 281(3):1741-5. PubMed ID: 16286469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase.
    McGowan S; Porter CJ; Lowther J; Stack CM; Golding SJ; Skinner-Adams TS; Trenholme KR; Teuscher F; Donnelly SM; Grembecka J; Mucha A; Kafarski P; Degori R; Buckle AM; Gardiner DL; Whisstock JC; Dalton JP
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2537-42. PubMed ID: 19196988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.
    Skinner-Adams TS; Lowther J; Teuscher F; Stack CM; Grembecka J; Mucha A; Kafarski P; Trenholme KR; Dalton JP; Gardiner DL
    J Med Chem; 2007 Nov; 50(24):6024-31. PubMed ID: 17960925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parasite Metalo-aminopeptidases as Targets in Human Infectious Diseases.
    Aguado ME; Izquierdo M; González-Matos M; Varela AC; Méndez Y; Del Rivero MA; Rivera DG; González-Bacerio J
    Curr Drug Targets; 2023; 24(5):416-461. PubMed ID: 36825701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of aminopeptidases in haemoglobin degradation in Plasmodium falciparum-infected erythrocytes.
    Gavigan CS; Dalton JP; Bell A
    Mol Biochem Parasitol; 2001 Sep; 117(1):37-48. PubMed ID: 11551630
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.